4//SEC Filing
OPTIMER PHARMACEUTICALS INC 4
Accession 0001142576-13-000027
CIK 0001142576operating
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 7:39 PM ET
Size
6.9 KB
Accession
0001142576-13-000027
Insider Transaction Report
Form 4
Sirota Eric
Chief Operating Officer
Transactions
- Disposition to Issuer
Common stock
2013-10-24$10.75/sh−2,129$22,887→ 0 total - Disposition to Issuer
Common stock
2013-10-24$10.75/sh+10,000$107,500→ 0 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 30, 2013 (the "Merger Agreement"), among Optimer Pharmaceuticals, Inc. ("Optimer"), Cubist Pharmaceuticals, Inc. ("Cubist"), and PDRS Corporation, each award was converted into the right to receive per share consideration of: (i) $10.75 cash and (ii) one contingent value right issued by Cubist in accordance with the Contingent Value Rights Agreement, dated as of October 24, 2013, between Cubist and American Stock Transfer & Trust Company, LLC (together, the "Per Share Merger Consideration") with respect to each share of Optimer common stock subject to the award.
- [F2]Pursuant to the terms of the Merger Agreement, each award was fully vested and converted into the right to receive the Per Share Merger Consideration with respect to each share of Optimer common stock subject to the award.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeoperating
Related Parties
1- filerCIK 0001142576
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 7:39 PM ET
- Size
- 6.9 KB